Candriam SCA’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.05M Sell
58,646
-51,636
-47% -$4.63M 0.03% 388
2025
Q4
$9.63M Sell
110,282
-17,647
-14% -$1.34M 0.05% 275
2025
Q3
$7.33M Sell
127,929
-43,909
-26% -$2.53M 0.04% 313
2025
Q2
$10.1M Buy
171,838
+22,783
+15% +$1.47M 0.06% 255
2025
Q1
$10.9M Buy
149,055
+41,132
+38% +$3.4M 0.07% 226
2024
Q4
$8.93M Sell
107,923
-9,766
-8% -$770K 0.05% 279
2024
Q3
$8.42M Buy
117,689
+40,023
+52% +$2.83M 0.05% 289
2024
Q2
$5.32M Sell
77,666
-13,126
-14% -$784K 0.03% 332
2024
Q1
$4.87M Buy
90,792
+37,735
+71% +$2.03M 0.03% 345
2023
Q4
$2.83M Sell
53,057
-3,574
-6% -$174K 0.02% 431
2023
Q3
$2.81M Sell
56,631
-71,717
-56% -$4.01M 0.02% 399
2023
Q2
$7.64M Buy
128,348
+48,774
+61% +$2.78M 0.06% 282
2023
Q1
$4.15M Buy
79,574
+15,000
+23% +$962K 0.03% 407
2022
Q4
$4.8M Sell
64,574
-15,000
-19% -$1.02M 0.03% 388
2022
Q3
$4.74M Sell
79,574
-12,328
-13% -$742K 0.03% 388
2022
Q2
$5.16M Sell
91,902
-17,444
-16% -$1.15M 0.04% 320
2022
Q1
$8.07M Buy
109,346
+50,346
+85% +$3.5M 0.05% 282
2021
Q4
$4.26M Hold
59,000
0.03% 387
2021
Q3
$4.52M Buy
59,000
+24,000
+69% +$1.93M 0.03% 418
2021
Q2
$2.71M Buy
+35,000
New +$2.49M 0.02% 528
2017
Q2
Sell
-50,000
Closed -$1.48M 711
2017
Q1
$1.48M Hold
50,000
0.03% 495
2016
Q4
$1.24M Hold
50,000
0.03% 476
2016
Q3
$1.13M Hold
50,000
0.03% 472
2016
Q2
$1.19M Sell
50,000
-14,000
-22% -$336K 0.03% 403
2016
Q1
$1.51M Buy
64,000
+28,000
+78% +$684K 0.04% 365
2015
Q4
$1M Buy
+36,000
New +$904K 0.03% 385

Other funds holding GMED